1. Home
  2. RPID vs BDSX Comparison

RPID vs BDSX Comparison

Compare RPID & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPID
  • BDSX
  • Stock Information
  • Founded
  • RPID 2006
  • BDSX 2005
  • Country
  • RPID United States
  • BDSX United States
  • Employees
  • RPID N/A
  • BDSX N/A
  • Industry
  • RPID Medical Specialities
  • BDSX Precision Instruments
  • Sector
  • RPID Health Care
  • BDSX Health Care
  • Exchange
  • RPID Nasdaq
  • BDSX Nasdaq
  • Market Cap
  • RPID 138.9M
  • BDSX 115.4M
  • IPO Year
  • RPID 2021
  • BDSX 2020
  • Fundamental
  • Price
  • RPID $3.78
  • BDSX $0.37
  • Analyst Decision
  • RPID Strong Buy
  • BDSX Strong Buy
  • Analyst Count
  • RPID 2
  • BDSX 5
  • Target Price
  • RPID $8.00
  • BDSX $1.75
  • AVG Volume (30 Days)
  • RPID 91.6K
  • BDSX 1.1M
  • Earning Date
  • RPID 08-08-2025
  • BDSX 08-07-2025
  • Dividend Yield
  • RPID N/A
  • BDSX N/A
  • EPS Growth
  • RPID N/A
  • BDSX N/A
  • EPS
  • RPID N/A
  • BDSX N/A
  • Revenue
  • RPID $29,645,000.00
  • BDSX $74,463,000.00
  • Revenue This Year
  • RPID $18.54
  • BDSX $17.29
  • Revenue Next Year
  • RPID $20.55
  • BDSX $29.33
  • P/E Ratio
  • RPID N/A
  • BDSX N/A
  • Revenue Growth
  • RPID 28.36
  • BDSX 35.76
  • 52 Week Low
  • RPID $0.66
  • BDSX $0.17
  • 52 Week High
  • RPID $4.50
  • BDSX $2.04
  • Technical
  • Relative Strength Index (RSI)
  • RPID 54.24
  • BDSX 56.88
  • Support Level
  • RPID $3.65
  • BDSX $0.29
  • Resistance Level
  • RPID $4.50
  • BDSX $0.46
  • Average True Range (ATR)
  • RPID 0.30
  • BDSX 0.04
  • MACD
  • RPID 0.03
  • BDSX 0.01
  • Stochastic Oscillator
  • RPID 47.45
  • BDSX 53.07

About RPID Rapid Micro Biosystems Inc.

Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Share on Social Networks: